CSPC Pharmaceutical Group Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CSPC Pharmaceutical Group Ltd with three other
companies in this sector in Hong Kong:
The United Laboratories International Holdings Limited
sales of 7.90 billion Hong Kong Dollars [US$1.01 billion]
of which 42%
was Bulk Medicine),
China Traditional Chinese Medicine Holdings Co Ltd
(9.65 billion Hong Kong Dollars [US$1.23 billion]
of which 66%
was Concentrated TCM Granules), and
Sino Biopharmaceutical Limited
(17.15 billion Hong Kong Dollars [US$2.19 billion]
of which 97%
was Modernized Chinese Medicines and Chemica).
CSPC Pharmaceutical Group Ltd reported sales of HK$15.46 billion (US$1.97 billion)
December of 2017.
increase of 25.0%
versus 2016, when the company's sales were HK$12.37 billion.
Sales at CSPC Pharmaceutical Group Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 273%).
Sales of Vitamin C Series saw an increase
40.3% in 2017, from
HK$1.32 billion to HK$1.85 billion.
Not all segments of CSPC Pharmaceutical Group Ltd experienced an increase in sales in 2017:
sales of Antibiotics Series fell 13.6% to HK$1.22 billion.